Press release
Stem Cell Therapy Market Outlook 2025-2033 | Driving Industry Growth Globally, Key Players - MEDIPOST Co., Ltd., ANTEROGEN.CO., LTD., CORESTEMCHEMON Inc., PHARMICELL Co., Ltd, and JCR Pharmaceuticals Co., Ltd.
Stem Cell Therapy Market Size
In 2022, North America led the Stem Cell Therapy Market with a valuation of US$ 6.23 billion, which further grew to US$ 6.48 billion in 2023.
Asia-Pacific demonstrated robust growth, rising from US$ 3.19 billion in 2022 to US$ 3.35 billion in 2023, driven by increasing investments and heightened demand in emerging markets such as China and India.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/stem-cell-therapy-market?kb
United States: Recent Industry Developments
✅ October 2025: Fate Therapeutics advanced clinical trials for allogeneic stem cell therapies targeting blood cancers.
✅ September 2025: Novartis expanded its CAR-T cell therapy portfolio incorporating stem cell approaches for autoimmune diseases.
✅ December 2025: FDA approved a novel stem cell-based treatment for degenerative joint disorders, improving patient mobility.
Japan: Recent Industry Developments
✅ October 2025: Kyoto University initiated regenerative medicine projects focusing on induced pluripotent stem cell (iPSC) therapies for neurodegenerative diseases.
✅ September 2025: Takeda Pharmaceutical advanced stem cell therapy trials for cardiac repair following myocardial infarction.
✅ December 2025: Government increased funding for stem cell research to accelerate translational applications in tissue regeneration.
GCC: Recent Industry Developments
✅ October 2025: Dubai Health Authority launched stem cell therapy centers specializing in hematological disorders and diabetes management.
✅ September 2025: Saudi Arabia invested in stem cell biobanks to support personalized regenerative therapies.
✅ December 2025: Collaborative research programs established between GCC universities and global biotech firms to advance stem cell technologies.
List of Top Key Player:
Mesoblast Ltd, Lineage Cell Therapeutics, Inc., BlueRock Therapeutics LP, Orchard Therapeutics plc., Vericel Corporation., CRISPR Therapeutics AG, Fate Therapeutics, Inc., Novartis AG, Bristol Myers Squibb (Juno Therapeutics, Inc.), Bluebird bio, Inc., MEDIPOST Co., Ltd., ANTEROGEN.CO., LTD., CORESTEMCHEMON Inc., PHARMICELL Co., Ltd, and JCR Pharmaceuticals Co., Ltd.
Industry Developments:
January 2026
• New clinical trials initiated focusing on regenerative treatments for neurodegenerative diseases.
• Major biotech firm announced a breakthrough in scalable stem cell manufacturing.
• Regulatory body approves advanced stem cell therapy for cardiac repair in select markets.
December 2025
• Partnership formed between leading pharma and research institutes to accelerate stem cell drug development.
• Emerging startups introduced novel stem cell delivery systems enhancing treatment precision.
• Investment surge observed in stem cell startups driven by growing demand for personalized medicine.
November 2025
• Publication of a landmark study showcasing improved outcomes in stem cell treatment for spinal cord injuries.
• Advances in gene editing integrated with stem cell therapy to target rare genetic disorders.
• Regulatory frameworks updated to facilitate faster approvals of stem cell-based regenerative products.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=stem-cell-therapy-market?kb
Forecast Projection:
The Global Stem Cell Therapy Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.
Market Key Segmentations:
By Product
• Aneurysm Coiling & Embolization Devices: Hold a leading share due to minimally invasive treatment preference for aneurysms.
• Cerebral Balloon Angioplasty and Stenting Systems: Growing adoption driven by improved outcomes in cerebral artery stenosis.
• Support Devices: Significant share supported by auxiliary technologies enhancing therapy delivery.
• Neurothrombectomy Devices: Rapid growth fueled by stroke treatment advancements and acute ischemic stroke interventions.
• Other: Includes emerging innovative devices contributing to expanding treatment options.
By Disease
• Aneurysm: Largest segment, reflecting high demand for effective vascular repair therapies.
• Ischemic Strokes: Strong growth driven by increasing stroke incidence and improved neurovascular intervention techniques.
• Cerebral Aneurysms: Notable market portion due to critical need for early diagnosis and treatment.
• Arteriovenous Malformation and Fistulas: Steady growth supported by advancements in endovascular therapy.
• Other: Encompasses rare neurovascular disorders benefiting from stem cell-based therapeutic research.
Regional Growth Analysis:
⇥ North America - 42%
Dominates due to advanced R&D, strong regulatory support, and high healthcare expenditure.
⇥ Europe - 28%
Significant share driven by growing clinical trials and increasing adoption of regenerative medicine.
⇥ Asia-Pacific - 20%
Rising demand fueled by expanding healthcare infrastructure and government initiatives in regenerative therapies.
⇥ Middle East & Africa - 6%
Gradual growth supported by increasing awareness and investment in advanced medical treatments.
⇥ South America - 4%
Emerging market with growing research activities and improving healthcare access.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/stem-cell-therapy-market?kb
Latest Mergers & Acquisitions Update
✦ STEMCELL Technologies acquired Cellular Highways Ltd from TTP Group on June 2, 2025, adding the Highway1 cell sorter (ISO 13485 certified) for fragile cell handling in gene therapy manufacturing. Broader biopharma deals indirectly supported stem cell via neurology (J&J-Intra-Cellular $14.6B) and RNA platforms (Novartis-Avidity $12B), but lacked direct stem cell therapy targets.
New Therapies on Market
No entirely new stem cell therapies launched commercially in 2025; focus remained on expanded access programs and Phase III readouts. Aspen Neuroscience advanced iPSC-derived neurons for Parkinson's (preclinical to IND 2025), while Mogrify's transcription factor reprogramming entered Phase I for hair loss and hearing. Cellino Bio scaled AI-laser iPSC production for personalized retinal therapies.
Drugs Introduced to Stem Cell Therapy
Haploidentical stem cell transplants increasingly incorporated PTCy (post-transplant cyclophosphamide) as standard for GVHD prophylaxis, improving outcomes over ATG (anti-thymocyte globulin) in 2025 meta-analyses. Rezurock (belumosudil), acquired by Sanofi via Kadmon (2021, 2025 expansion), became frontline for chronic GVHD post-stem cell transplant.
Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
FDA Approvals (2025)
• Brexucabtagene autoleucel (Tecartus) expanded label for mantle cell lymphoma (March 2025), leveraging allogeneic stem cell rescue.
• Lisocabtagene maraleucel (Breyanzi) gained approval for follicular lymphoma (August 2025), often paired with stem cell support.
• First-in-class iPSC therapies remain IND-stage, with Vertex's VX-880 (Phase I/II diabetes) showing 1-year insulin independence in 2025 updates.
• Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stem Cell Therapy Market Outlook 2025-2033 | Driving Industry Growth Globally, Key Players - MEDIPOST Co., Ltd., ANTEROGEN.CO., LTD., CORESTEMCHEMON Inc., PHARMICELL Co., Ltd, and JCR Pharmaceuticals Co., Ltd. here
News-ID: 4350214 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Basal Cell Carcinoma Treatment Market to Reach US$ 19.6 Billion by 2032 at 9.8% …
The Basal Cell Carcinoma Treatment Market reached US$ 8.9 billion in 2024 and is expected to reach US$ 19.6 billion by 2032, growing at a CAGR of 9.8% during the forecast period 2025-2032. The market is expanding steadily due to the rising incidence of skin cancer worldwide, particularly among aging populations and individuals with prolonged exposure to ultraviolet radiation.
Growth is driven by advancements in targeted therapies, immunotherapies, and minimally invasive…
Tobacco Testing Market Is set to growth at a CAGR of 4.3%, Asia Pacific leads th …
Tobacco Testing Market is estimated to reach at a CAGR of 4.3% during the forecast period 2024-2031.
The Tobacco Testing Market is growing due to rising health regulations, demand for safer tobacco products, and quality compliance. North America leads, followed by Europe and Asia Pacific, driving regional growth.
DataM Intelligence unveils its latest report on the "Tobacco Testing Market size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape,…
Vehicle Subscription Market Set for Explosive Growth to USD 18.2 Billion by 2030 …
The Global Vehicle Subscription Market reached USD 3.2 billion in 2022 and is expected to reach USD 18.2 billion by 2030, growing at a robust CAGR of 24.2% during the forecast period 2023-2030.
Market growth is driven by shifting consumer preferences toward flexible mobility solutions, the rise of digital platforms enabling seamless subscriptions, and automakers' strategies to boost recurring revenue streams. Advancements in connected vehicle technologies, expanding partnerships between OEMs and…
United States Neurovascular Devices Market to Reach US$ 7.78 Billion by 2033 | S …
neurovascular devices market size reached US$ 3.82 Billion in 2024 from US$3.55 Billion in 2023 and is expected to reach US$ 7.78 Billion by 2033, growing at a CAGR of 8.3% during the forecast period 2025-2033.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neurovascular-devices-market?kb
United States: Recent Industry Developments
✅ October 2025: Medtronic received FDA approval for a next-generation neurovascular stent system designed to treat…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
